TNFAIP6 and bronchopulmonary dysplasia: To summarize, our results demonstrates that the therapeutic effects of the secretome of UC MSCs resides in the EXO fraction, and specifically, TSG-6 is one of the mediators in the 25 wks GA MSC-CM EXO, responsible for the attenuation of BPD pathology (Fig. 10).